Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2001
10/25/2001WO2001079287A2 Steatosis-modulating factors and uses thereof
10/25/2001WO2001079286A2 Compositions and methods for the therapy and diagnosis of breast cancer
10/25/2001WO2001079284A2 Therapeutic compounds and methods for formulating v3, a versican isoform
10/25/2001WO2001079282A2 Molecules associated with human reproduction
10/25/2001WO2001079281A1 Sheep lice, bovicola ovis, allergen treatment
10/25/2001WO2001079269A2 Lipid binding protein 4
10/25/2001WO2001079253A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001WO2001079252A1 ASSOCIATION OF β2-ADRENERGIC RECEPTOR HAPLOTYPES WITH DRUG RESPONSE
10/25/2001WO2001079250A1 Enhanced protein thermostability and temperature resistance
10/25/2001WO2001079249A2 Peptide nucleic acid derivatives with a negative charge, agents and methods for producing them
10/25/2001WO2001079240A2 Haplotypes of the rangap1 gene
10/25/2001WO2001079239A2 Haplotypes of the ghrhr gene
10/25/2001WO2001079238A2 Haplotypes of the mmp3 gene
10/25/2001WO2001079237A2 Haplotypes of the galr1 gene
10/25/2001WO2001079236A2 Haplotypes of the scya1 gene
10/25/2001WO2001079235A2 Haplotypes of the dnal4 gene
10/25/2001WO2001079234A2 Haplotypes of the apoe gene
10/25/2001WO2001079233A2 Haplotypes of the dtr gene
10/25/2001WO2001079232A2 Haplotypes of the mpl gene
10/25/2001WO2001079231A2 Haplotypes of the npr1 gene
10/25/2001WO2001079230A2 Haplotypes of the ugt1a1 gene
10/25/2001WO2001079229A2 Haplotypes of the cxcr4 gene
10/25/2001WO2001079228A2 Haplotypes of the f12 gene
10/25/2001WO2001079227A2 Haplotypes of the pi4 gene
10/25/2001WO2001079226A2 Haplotypes of the zfp36 gene
10/25/2001WO2001079224A2 Haplotypes of the cyp8b1 gene
10/25/2001WO2001079223A2 Haplotypes of the akr1b1 gene
10/25/2001WO2001079221A2 Haplotypes of the il8rb gene
10/25/2001WO2001079220A2 Haplotypes of the hrh2 gene
10/25/2001WO2001079218A2 Haplotypes of the calm1 gene
10/25/2001WO2001079217A2 Haplotypes of the scya3 gene
10/25/2001WO2001079216A2 Polyamide nucleic acid derivatives, agents and methods for producing them
10/25/2001WO2001078894A2 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
10/25/2001WO2001078796A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
10/25/2001WO2001078721A1 Aβ42 LOWERING AGENTS
10/25/2001WO2001078575A2 Ext2 as a predictive marker for osteoporosis
10/25/2001WO2001040512A3 Resistance gene
10/25/2001WO2001040499A3 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses
10/25/2001WO2001039786A3 New uses of suppressive macrophage activation factors
10/25/2001WO2001038584A3 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
10/25/2001WO2001030489A3 Device and method for hybridizing double-stranded dna samples on oligomer arrays
10/25/2001WO2001023583A3 Thermostable enzyme promoting the fidelity of thermostable dna polymerases- for improvement of nucleic acid synthesis and amplification in vitro
10/25/2001WO2001023570A3 Methods and compositions relating to sodium channel beta-1a subunits
10/25/2001WO2001022092A3 Method to identify compounds which modulate fra-1 expression fils
10/25/2001WO2001022091A3 Method for determining the fertility of mammals, especially of humans
10/25/2001WO2001021838A3 Three-dimensional microarray system for parallel genotyping of single nucleotide polymorphisms
10/25/2001WO2001021758A3 Colorimetric test for agents that induce mitrochondrial dysfunction
10/25/2001WO2001018252A3 Methods for disease detection
10/25/2001WO2001012790A3 Isomerase proteins
10/25/2001WO2001012663A3 Hematopoietic regulatory factors and methods of use thereof
10/25/2001WO2001006017A3 Methods for preparing quantities of preselected polynucleotide sequences and uses thereof
10/25/2001WO2001005957A3 Grapevine leafroll-associated virus proteins
10/25/2001WO2001000805A3 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
10/25/2001WO2000065090A3 The insulin receptor-related receptor gene sequence for diagnosis of human obesity and diabetic disorders
10/25/2001WO2000057187A9 Diagnosis and treatment of multiple sclerosis
10/25/2001WO2000053812A9 Replica amplification of nucleic acid arrays
10/25/2001WO2000052207A9 Nucleic acid ligand inhibitors to dna polymerases
10/25/2001WO2000047618A9 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES
10/25/2001WO2000043492A9 Method of site specific labeling of proteins and uses therefor
10/25/2001WO2000042907A9 System and method for noninvasive blood analyte measurements
10/25/2001WO2000011169A3 Human cell signaling proteins (csig)
10/25/2001US20010034884 Abeta-peptide screening assay
10/25/2001US20010034580 Methods for using functional site descriptors and predicting protein function
10/25/2001US20010034440 Complexing the target cell with therapeutic agent; antiproliferative agent
10/25/2001US20010034439 Transcriptional unit complementary to human telomerase RNA sequence linked to regulating sequences
10/25/2001US20010034437 Structural similarity with animal proteases like enteropep-tidase, plasminogen and acrosin; modulaters of the expression or activity of the proteins can be used for drug screening, medical diagnosis and physiological disorder treatment
10/25/2001US20010034436 Polynucleotide and polypeptides, screening for antibiotic activity, Staphylococcus
10/25/2001US20010034334 Genetic engineered polypeptide
10/25/2001US20010034332 Testing for drug resistance
10/25/2001US20010034327 Suppression of inhibitors
10/25/2001US20010034057 Using chromatography to remove specific inhibitors of the intended enzyme from the sample; allows determination of the portion of free and inhibited enzyme in the total amount of enzyme present
10/25/2001US20010034048 Complementary to a target polynucleotide sequence by hybridizing a single stranded DNA target template with a composite primer comprising an RNA protion and a 3'DNA portion; extending with a polymerase; cleaving the RNA
10/25/2001US20010034040 Growing a mycelia-producing cell type to allow it to produce a biomolecule or biactivity; screening for the bioactivity or biomolecule using a fluorescence analyzer; identifying clones from an expression library using a fluorescent activated cell
10/25/2001US20010034039 Specifically a YH9-RC, a Janthinobacterium lividum gramnegative bacteria, which reacts with toxic substances using an aldehyde as substrate; highly sensitive; water pollution; soil; colorimetric analysis
10/25/2001US20010034038 Isolated ductal fluid sample
10/25/2001US20010034033 Nucleic acid mediated electron transfer
10/25/2001US20010034032 Determining a subject's susceptibility to or the rapidity of progression of sepsis in a subject by detecting at least one allele of an Interleukin-1 proinflammatory haplotype in a nucleic acid sample which indicates increased susceptibility
10/25/2001US20010034031 Coencapsulating the agent being screened with a first protein linked to a DNA and a second protein linked to a transcriptional activation moiety to determine modulation by the agent; fluorescense-activated cell sorting; libraries
10/25/2001US20010034030 Acquiring a spectrum for a hybridization complex formed between a nucleic acid probe electromagnetically coupled to a portion of a signal path and a nucleic acid target by propagating a test signal and detecting hybridization signal
10/25/2001US20010034029 Fluorescent oligonucleotides are hybridized with corresponding ones of the inspected sites of the object of analysis, a homoduplex is formed having normal base sequence, and heteroduplex is formed having mutational base sequence
10/25/2001US20010034027 Microarray, method for producing the same, and method for correcting inter-pin spotting amount error of the same
10/25/2001US20010034026 Ex vivo generation of functional leukemia cells in a three-dimensional bioreactor
10/25/2001US20010034025 Locating a different reference polynucleotide at each assay site of the substrate, contacting sample polynucleotide at each assay site to conduct hybridization, labeling one of the polynucleotide with luminophore, detecting transmission light
10/25/2001US20010034024 Mutations in and genomic structure of HERG - a long QT syndrome gene
10/25/2001US20010034023 Identifying and predicting genetic based inter-patient differences in response to drugs in order to achieve superior efficacy and saftey in selected patient population; pharmacokinetics and toxicology
10/25/2001US20010034022 Providing a sample suspected of containing enterovirus and a mixed cell culture comprising Rhabdomyosarcoma cells and human mucoepidermoid cells, inoculating mixed cell culture with sample, observing inoculated culture for enterovirus
10/25/2001US20010034020 Methods for the detection, quantification and differentiation of infectious versus non-infectious pathogens in a sample
10/25/2001US20010034018 Contacting a sample with an antibody which binds to SVI (Sentinel virus 1) or a protein and the antibody does not bind TTV strains SANBAN and TUS01 or protiens and detecting the complexes of antibody and SVI virus or protein
10/25/2001US20010033796 Microfabricated elastomeric valve and pump sysems
10/25/2001US20010033364 Spectral bio-imaging of the eye
10/25/2001EP1144653A3 THERMOSTABLE ENZYME PROMOTING THE FIDELITY OF THERMOSTABLE DNA POLYMERASES- FOR IMPROVEMENT OF NUCLEIC ACID SYNTHESIS AND AMPLIFICATION i IN VITRO /i
10/25/2001DE10019901A1 New isolated nucleic acid encoding an apoptase, useful e.g. for diagnosis and treatment of apoptosis-related, especially neurodegenerative, diseases
10/25/2001DE10018368A1 Screening for kinase able to phosphorylate 1-deoxy-D-xylulose, useful for producing the 5-phosphate, an intermediate for vitamins and terpenoids
10/25/2001CA2798625A1 Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins
10/25/2001CA2407064A1 Screening assay methods and systems using target pooling
10/25/2001CA2406955A1 Sheep lice, bovicola ovis, allergen treatment
10/25/2001CA2406618A1 Method and apparatus for dna sequencing
10/25/2001CA2406481A1 Trp8, a transient receptor potential channel expressed in taste receptor cells
10/25/2001CA2406383A1 A.beta.42 lowering agents
10/25/2001CA2406346A1 Genetic testing for determining the risk of pouchitis development
1 ... 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 ... 3003